Cargando…
Timing of the infusion of nivolumab for patients with recurrent or metastatic squamous cell carcinoma of the esophagus influences its efficacy
BACKGROUND: The immune system is affected by the circadian rhythm. The objective of this study was to clarify whether time-of-day patterns (early or late in the daytime) of the infusion of nivolumab and whether its duration affect treatment efficacy in metastatic or recurrent esophageal squamous cel...
Autores principales: | Nomura, Motoo, Hosokai, Taisuke, Tamaoki, Masashi, Yokoyama, Akira, Matsumoto, Shigemi, Muto, Manabu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123478/ https://www.ncbi.nlm.nih.gov/pubmed/37093536 http://dx.doi.org/10.1007/s10388-023-01006-y |
Ejemplares similares
-
Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors
por: Nomura, Motoo, et al.
Publicado: (2020) -
Readministration of Nivolumab after Persistent Immune-related Colitis in a Patient with Recurrent Melanoma
por: Fujii, Yosuke, et al.
Publicado: (2017) -
Femoral placement of a totally implantable venous access port with spontaneous catheter fracture: case report
por: Kondo, Tomohiro, et al.
Publicado: (2020) -
A case of long-term survival treated with three metastasectomies and two subsequent adjuvant nivolumab therapies for recurrent malignant melanoma of the esophagus
por: Hanada, Keita, et al.
Publicado: (2022) -
Comprehensive genomic profiling for patients with chemotherapy‐naïve advanced cancer
por: Kondo, Tomohiro, et al.
Publicado: (2020)